Cathrin Schleussner

Cathrin Schleussner currently works at T-Balance Therapeutics GmbH, as Chief Executive Officer, OGEL Next GmbH, as Managing Director from 2018, CaVeBel GmbH, as Managing Director, and Bürger­hospital und Clementine Kinder­hospital gGmbH, as Member-Supervisory Board.
Dr. Schleussner also formerly worked at OGEL GmbH, as Chief Executive Officer from 2007 to 2014 and Biotest AG, as Deputy Chairman-Supervisory Board.
Dr. Schleussner received her doctorate degree from the University of Freiburg.